AbbVie today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of upadacitinib (RINVOQ®; 15 ...

CLF065, a long-acting, once-weekly GLP-2 receptor agonist, advances in two inflammatory bowel disease indications. The studies aim to bring a regenerative treatment option to patients living with IBD, ...

Aewin announced a push into two-phase direct liquid cooling to address rising data center thermal demands as rack power consumption moves past 100kW, with demonstrations and product plans shown at ...

My Alerts is a service for subscribers. Please login or subscribe in order to use My Alerts. Shell-led LNG Canada has issued a limited notice to proceed to its lead contractors for the proposed second ...

Are efforts to target tau finally starting to pay off? Just a little, maybe? The Tau Global Conference, held in Washington, D.C., May 14 to 15, showcased recent progress in basic science, biomarkers, ...

The Catawba Nation opened phase one of its $1 billion Catawba Two Kings Casino today after years of delays and setbacks. Melissa Key/CBJ To continue reading this ...

Novartis is ending its work on the antibody abelacimab for cancer-associated thrombosis. (iStock / Getty Images Plus) A little over a year after reabsorbing its anticoagulant abelacimab, Novartis has ...

👉 Learn how to divide polynomials using the long division algorithm. To be able to solve a polynomial, we need to be able to get the factors and hence the zeros. To get the factors, we use the ...

Even if you don’t know much about the inner workings of generative AI models, you probably know they need a lot of memory. Hence, it is currently almost impossible to buy a measly stick of RAM without ...

Neuroinflammation and neuroimmune dysfunction are increasingly recognized as key contributors to AD pathophysiology, particularly in early disease stages. Semaglutide, already approved for type 2 ...